Skip to main content

Advertisement

Table 2 Health-related quality of life (HRQOL) scores according to physical activity levels among breast cancer survivors with stage I to III breast cancer

From: The association between physical activity and health-related quality of life among breast cancer survivors

HRQOL Items Physical Activity (MET-hours per week)
All Tertile 1 Tertile 2 Tertile 3 P for trenda
EORTC QLQ-C30, LS means (95% CI)b
Global health status / QoL 206 45.25 (33.62, 60.90) 31.99 (23.14, 44.22) 40.10 (29.17, 55.12) 0.64
Functioning
 Physical Functioning 229 78.44 (70.20, 87.65) 81.12 (71.93, 91.48) 82.53 (73.21, 93.05) 0.41
 Role Functioning 230 75.68 (59.77, 95.82) 83.78 (64.68, 108.51) 90.10 (69.98, 116.01) 0.18
 Emotional Functioning 231 75.16 (62.37, 90.58) 72.87 (59.47, 89.31) 75.67 (61.95, 92.44) 0.89
 Cognitive Functioning 231 75.13 (63.80, 88.47) 72.40 (60.60, 86.51) 71.47 (59.98, 85.16) 0.59
 Social Functioning 231 56.74 (44.62, 72.15) 73.08 (56.25, 94.94) 72.96 (56.39, 94.39) 0.08
Symptom
 Fatigue 230 21.63 (16.07, 29.11) 21.00 (15.20, 29.02) 13.30 (9.64, 18.36) 0.001
 Nausea / Vomiting 231 2.56 (1.60, 4.09) 2.33 (1.40, 3.89) 2.54 (1.53, 4.20) 0.97
 Pain 230 12.45 (7.44, 20.83) 7.90 (4.51, 13.83) 6.25 (3.58, 10.93) 0.02
 Dyspnea 228 5.83 (3.38, 10.03) 3.23 (1.79, 5.85) 4.07 (2.25, 7.37) 0.35
 Insomnia 229 12.60 (7.38, 21.53) 15.79 (8.81, 28.29) 16.22 (9.07, 29.00) 0.42
 Appetite loss 228 2.22 (1.33, 3.70) 2.69 (1.54, 4.69) 2.10 (1.21, 3.65) 0.72
 Constipation 229 3.69 (2.09, 6.52) 4.36 (2.35, 8.09) 3.62 (1.95, 6.69) 0.86
 Diarrhea 231 2.95 (1.77, 4.91) 2.26 (1.30, 3.95) 2.35 (1.36, 4.07) 0.48
 Financial Problems 231 4.46 (2.56, 7.77) 5.96 (3.26, 10.90) 3.29 (1.81, 5.95) 0.19
EORTC QLQ-BR23, LS means (95% CI)b
Functioning
 Body image 231 36.03 (24.05, 54.00) 34.95 (22.49, 54.30) 32.14 (20.83, 49.58) 0.58
 Sexual functioning 209 2.69 (1.53, 4.71) 2.57 (1.43, 4.65) 5.34 (3.04, 9.39) 0.007
 Sexual enjoyment 69 16.89 (4.80, 59.47) 9.65 (3.14, 29.62) 11.54 (3.34, 39.90) 0.56
 Future perspective 231 17.83 (10.65, 29.83) 18.04 (10.29, 31.60) 19.72 (11.35, 34.24) 0.70
Symptom
 Systematic therapy side effects 231 21.59 (16.54, 28.19) 23.55 (17.62, 31.49) 19.06 (14.32, 25.36) 0.29
 Breast symptoms 231 12.45 (8.04, 19.28) 10.06 (6.25, 16.20) 10.42 (6.52, 16.65) 0.52
 Arm symptoms 231 18.20 (12.41, 26.69) 21.04 (13.86, 31.93) 17.92 (11.89, 27.02) 0.83
 Upset by hair loss 157 17.28 (8.92, 33.50) 14.78 (7.09, 30.83) 17.59 (8.60, 36.00) 0.90
  1. MET metabolic equivalent, EORTC QLQ-C30 European organization for research and treatment of cancer quality of life questionnaire core 30, LS least-squares, CI confidence interval, EORTC QLQ-BR23 European organization for research and treatment of cancer quality of life questionnaire breast cancer module 23
  2. aP for trend was calculated using the median value of each tertile category as a continuous variable
  3. bAdjusted for age (year: continuous), energy intake (kcal/day: continuous), dietary supplement use (yes, no), education level (high school or less, college or more), marital status (married or cohabitated, unmarried or divorced or widowed), time since surgery (6 month – 1 year, 1 year - 5 years, ≥5 years), stage (I, II, or III), and center